What Researchers Did
Researchers conducted a randomized clinical trial with 82 patients with advanced cervical cancer, comparing external irradiation in air or hyperbaric oxygen (HBO) combined with intracavitary irradiation.
What They Found
The study reported an overall 69% local control and 40% survival at five years. However, hyperbaric oxygen did not show an improvement in outcomes, and 13% of patients experienced late small bowel damage, with a non-statistically significant higher incidence in the HBO group.
What This Means for Canadian Patients
This 1979 study suggests that adding hyperbaric oxygen therapy to radiotherapy for advanced cervical cancer may not provide additional clinical benefits. Canadian patients should consult with their oncologists about current evidence-based treatments, as cancer care has advanced significantly since this research.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A significant limitation is that the study was conducted in 1979, meaning the radiotherapy techniques and overall understanding of cancer treatment have advanced considerably since then.